GLG-V-13

N/A

Report date: 2025/02/05 13:46:33
NME

Base Information

Drug NameGLG-V-13
Drug Alias NameGLG-V-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOklahoma State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOklahoma State University
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A